IIM

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
Mercredi, mai 15, 2024
Patient, Cell, Systemic scleroderma, Movement, Lupus, Pemphigus vulgaris, Food, Myopathy, Investment, Letter, CD19, FDA, Disease, MuSK protein, MPV, Conference, Cytokine release syndrome, Dermatology, Congress, Growth, Gene, Immunoglobulin therapy, Potential, Juvenile dermatomyositis, Cyclophosphamide, Dermatomyositis, Symposia, EULAR, IIM, Society, Health Canada, A1, Observation, Research, Clinical trial, DLT, Myositis, Annual general meeting, CRS, Pharmaceutical industry

PHILADELPHIA, May 15, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.

Key Points: 
  • PHILADELPHIA, May 15, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.
  • In March 2024, Cabaletta announced the first patient had been dosed in the Phase 1/2 RESET-Myositis trial.
  • Cabaletta expects to report initial clinical data from the Phase 1/2 RESET-SSc™ trial in the second half of 2024.
  • Cabaletta expects to report initial clinical data from the Phase 1/2 RESET-MG™ trial in the second half of 2024.

Esperanto Technologies and Rapidus Partner to Enable More Energy-Efficient Designs for the Coming “Post GPU Era”

Retrieved on: 
Mercredi, mai 15, 2024
Data Management, Technology, Semiconductor, Telecommunications, Apps, Applications, Software, Artificial Intelligence, Networks, Internet, Mobile, Wireless, Hardware, Partnership, IEA, Intelligence, International Energy Agency, Kilowatt-hour, Innovation, Integration, Rapidus, AI, Growth, Research, Graphics processing unit, Silicon, TTM, Esperanto, IIM, Generative, Electricity, HPC, Synthetic media, Management

In their recent report “Electricity 2024,” the International Energy Agency (IEA) stated, “Data centers are significant drivers of the growth in electricity demand.

Key Points: 
  • In their recent report “Electricity 2024,” the International Energy Agency (IEA) stated, “Data centers are significant drivers of the growth in electricity demand.
  • After globally consuming an estimated 460 terawatt-hours (TWh) in 2022, data centers’ total electricity consumption could reach more than 1,000 TWh in 2026.
  • Rapidus plans to start operation of a pilot production line at IIM-1 (the first fab) in April 2025, and begin mass production in 2027.
  • “The strategic partnership with Rapidus plays a key role in our expansion plans, particularly in Japan.

Esperanto Technologies and Rapidus Partner to Enable More Energy-Efficient Designs for the Coming “Post GPU Era”

Retrieved on: 
Mercredi, mai 15, 2024
Semiconductor, Data Management, Technology, Artificial Intelligence, Software, Partnership, IEA, Intelligence, International Energy Agency, Kilowatt-hour, Innovation, Integration, Rapidus, AI, Growth, Research, Graphics processing unit, Silicon, TTM, Esperanto, IIM, Generative, Electricity, HPC, Synthetic media, Management

In their recent report “Electricity 2024,” the International Energy Agency (IEA) stated, “Data centers are significant drivers of the growth in electricity demand.

Key Points: 
  • In their recent report “Electricity 2024,” the International Energy Agency (IEA) stated, “Data centers are significant drivers of the growth in electricity demand.
  • After globally consuming an estimated 460 terawatt-hours (TWh) in 2022, data centers’ total electricity consumption could reach more than 1,000 TWh in 2026.
  • Rapidus plans to start operation of a pilot production line at IIM-1 (the first fab) in April 2025, and begin mass production in 2027.
  • “The strategic partnership with Rapidus plays a key role in our expansion plans, particularly in Japan.

Azure Power appoints Chairman of the Board of Directors

Retrieved on: 
Jeudi, mai 9, 2024
Corporation, Azure Power, RBL Bank, Royal Bank of Scotland, Delhi University, Indian Institutes of Management, OTC, RBS, Wholesaling, Bank, Institution, MBA, Royal Bank, IIM, Growth, Renewable energy

Mr. Mehra shall also assume the role of Chairman of the Board of the Company and of Azure Power India Private Limited.

Key Points: 
  • Mr. Mehra shall also assume the role of Chairman of the Board of the Company and of Azure Power India Private Limited.
  • Speaking on this, Mr. Sunil Gupta, Chief Executive Officer, Azure Power, said, "We are pleased to have Brijesh join our Board as the Chairman.
  • The Indian renewable energy space is thriving, and Azure Power is well situated to capture its growth potential.
  • I look forward to working with the other members of the Board to lead Azure Power through its next phase of growth."

Azure Power appoints Chairman of the Board of Directors

Retrieved on: 
Jeudi, mai 9, 2024
Corporation, Azure Power, RBL Bank, Royal Bank of Scotland, Delhi University, Indian Institutes of Management, OTC, RBS, Wholesaling, Bank, Institution, MBA, Royal Bank, IIM, Growth, Renewable energy

Mr. Mehra shall also assume the role of Chairman of the Board of the Company and of Azure Power India Private Limited.

Key Points: 
  • Mr. Mehra shall also assume the role of Chairman of the Board of the Company and of Azure Power India Private Limited.
  • Speaking on this, Mr. Sunil Gupta, Chief Executive Officer, Azure Power, said, "We are pleased to have Brijesh join our Board as the Chairman.
  • The Indian renewable energy space is thriving, and Azure Power is well situated to capture its growth potential.
  • I look forward to working with the other members of the Board to lead Azure Power through its next phase of growth."

Bridgewest Group appoints Laxman Settipalli as General Manager of new Global Capability Center in India

Retrieved on: 
Mercredi, mai 8, 2024
Change management, Software, Growth, Kakatiya University, Automation, Lakshman (name), GCC, Computer, MBA, IIM, Information system, Management

MIAMI and HYDERABAD, India, May 8, 2024 /PRNewswire/ -- Global private investment firm, Bridgewest Group , recognized for developing innovative companies in life sciences, software, and deep tech, announce formation of new Global Capability Center, Bridgewest India, and new General Manager and India Head Laxman Settipalli.

Key Points: 
  • MIAMI and HYDERABAD, India, May 8, 2024 /PRNewswire/ -- Global private investment firm, Bridgewest Group , recognized for developing innovative companies in life sciences, software, and deep tech, announce formation of new Global Capability Center, Bridgewest India, and new General Manager and India Head Laxman Settipalli.
  • Settipalli will spearhead the establishment and growth of the center, driving operational excellence, and fostering innovation in support of the firm's global investment strategy.
  • Settipalli has a proven track record in creating and nurturing robust operational resources, driving business processes, automation, and transformation.
  • "The establishment of the Global Capability Center in India underscores our commitment to leveraging global talent and resources to drive innovation and maximize value for our portfolio companies.

Konica Minolta Achieves Micro-vertical Competency Status from Hyland

Retrieved on: 
Jeudi, avril 11, 2024
Organization, Konica Minolta, Information management, IIM, Scientific Research Publishing

Ramsey, NJ, April 11, 2024 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions U.S.A., Inc.  ( Konica Minolta ) today announced it has achieved micro-vertical competency status from Hyland.

Key Points: 
  • Ramsey, NJ, April 11, 2024 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions U.S.A., Inc.  ( Konica Minolta ) today announced it has achieved micro-vertical competency status from Hyland.
  • The Hyland competency program recognizes partners’ expertise in demonstrating, selling, implementing and supporting Hyland solutions.
  • To obtain each Hyland competency, partners are required to submit an application and participate in a thorough review process that validates their technical proficiency and customer success.
  • We’re proud to recognize Konica Minolta for their achievement in micro-vertical status as they continue to drive their business forward and create even better experiences for their customers,” said Eric Miller, Hyland’s associate vice president for Hyland Channel.

R Systems International Appoints Chief Customer Officer and Chief Marketing Officer to Deepen Client Relationships and Accelerate Growth

Retrieved on: 
Mercredi, avril 10, 2024
Semiconductor, Manufacturing, Other Technology, Software, Human Resources, Artificial Intelligence, Networks, Internet, Electronic Design Automation, Data Management, Professional Services, Technology, Mobile, Wireless, Digital Marketing, Data Analytics, Marketing, Communications, Engineering, CMO, Sanjay, Infosys, MD, Digital marketing, Digital, Gold, Workforce, IIT, MBA, IIM, Growth, NIT, Management

In a strategic move to deepen client relationships and accelerate its growth trajectory, R Systems International, backed by Blackstone, has strengthened its C-suite by appointing two seasoned executives: Arun Raghavapudi as Chief Customer Officer and Sanjay Sahay as Chief Marketing Officer.

Key Points: 
  • In a strategic move to deepen client relationships and accelerate its growth trajectory, R Systems International, backed by Blackstone, has strengthened its C-suite by appointing two seasoned executives: Arun Raghavapudi as Chief Customer Officer and Sanjay Sahay as Chief Marketing Officer.
  • Arun Raghavapudi joined R Systems as the Chief Customer Officer.
  • His expertise extends across the entire value chain of technology services, with a particular focus on ensuring client delight and successful project delivery.
  • His appointment marks a significant step in redefining R Systems’ marketing operating model to establish a digital-first marketing organization.

Rapidus announces U.S. subsidiary and opens Silicon Valley office; names Henri Richard as GM and president of Rapidus Design Solutions

Retrieved on: 
Jeudi, avril 11, 2024
Cloud, AMD, Organization, AI, Quantum computing, City, Partnership, Rapidus, Research, Semiconductor, SanDisk, Retirement, Silicon, Sony, NetApp, Marketing, RDS, IIM, IBM

Richard—who effectively came out of retirement to work for Rapidus— brings decades of leadership experience in sales, marketing and customer support to his new role.

Key Points: 
  • Richard—who effectively came out of retirement to work for Rapidus— brings decades of leadership experience in sales, marketing and customer support to his new role.
  • He's held executive positions at a wide range of industry-leading companies including AMD, Freescale, IBM, NetApp and SanDisk, among others.
  • Richard has strong relationships in the industry and has already assembled the core leadership team for Rapidus Americas sales and marketing.
  • "Working together with Rapidus engineers at the Albany NanoTech Complex, we are making tremendous strides for our 2nm joint development project."

Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Jeudi, mars 21, 2024
Research, MPV, IIM, MuSK protein, Toxicity, Conference, Disease, Dermatomyositis, Juvenile dermatomyositis, Federation, Patient, NOL, Observation, CRS, SLE, Health Canada, IND, Immunoglobulin therapy, Pemphigus, Investment, Investigational New Drug, Myopathy, Systemic scleroderma, Marketing, FDA, Clinical trial, Cytokine release syndrome, Cyclophosphamide, CD19, Food, Autoimmune disease, Pharmaceutical industry

In October 2023, Cabaletta received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA) for the Phase 1/2 RESET-SSc trial.

Key Points: 
  • In October 2023, Cabaletta received Investigational New Drug (IND) application clearance from the U.S. Food and Drug Administration (FDA) for the Phase 1/2 RESET-SSc trial.
  • In November 2023, Cabaletta announced that its IND application for CABA-201 was allowed to proceed by the FDA for the Phase 1/2 RESET-MG trial.
  • Cabaletta anticipates reporting initial clinical data from the Phase 1/2 RESET-MG trial in the second half of 2024.
  • As of December 31, 2023, Cabaletta had cash, cash equivalents and short-term investments of $241.2 million, compared to $106.5 million as of December 31, 2022.